Click here to read the articles and view the interactive digital edition
Pharma Pulse 6/11/25: Transforming Care for COPD; Pharmacists Provide Harm Reduction Services to Patients With Substance Use Disorder
The Connection Between Virtual Care and Language Barriers
A systematic review determines if adult patients with language barriers are less likely to use the video-based virtual care option, while exploring equity and accessibility gaps when it comes to telehealth.
Bridging Access Gaps
In the third part of her Pharma Commerce video interview, Maggie McCullough, PolicyMap’s CEO, comments on how mobile and digital solutions can be deployed effectively to close the gap in areas identified as pharmacy deserts.
Pharma Pulse 6/10/25: Exploring Perspectives of Fair Market Value in Clinical Trial Budgeting; New Technology Helps Prevent Opioid Overdose
Sanofi to Begin Globally Shipping Beyfortus Ahead of RSV Season
In an effort to greater prepare HCPs and to avoid potential shortages, the company targets Q3 as the shipment date.
How MFN Executive Order Could Affect International Drug Costs
Ron Lanton, Partner, Lanton Law, weighs in on the potential international trade, pricing, and access implications of tying US drug costs to those in other developed countries under the Most Favored Nation executive order.
Bridging the Gap Between Strategy and Practice in IDN Partnerships
In order to succeed in today’s outcomes-driven healthcare landscape, pharmaceutical companies must move from traditional sales models to strategic, measurable partnerships with integrated delivery networks (IDNs).
Pharma Pulse 6/9/25: Accelerating Site Activation and Recruitment with MCRC Partnerships; Avenzo Begins Phase I/II Trial of CDK4 Selective Inhibitor for Breast Cancer
The Variation in Dual-Eligible Beneficiary Characteristics across Medicare Advantage Plan Types
A cross-sectional study explores how full-benefit dual-eligible beneficiaries differ across MA plans with differing levels of Medicaid coordination and integration.
Mapping the Hidden Costs
In the second part of her Pharma Commerce video interview, Maggie McCullough, PolicyMap’s CEO, details what the company’s data reveals about the relationship between pharmacy access and broader health disparities in underserved communities.
Pharma Pulse 6/6/25: GLP-1 Drugs May be Linked to Elevated Risk of Serious Eye Disease; Incyte’s Zynyz Wins FDA Approval as Single and Combo Therapy for Anal Cancer
BioNTech, BMS to Co-Design and Co-Commercialize New Antibody Candidate for Various Types of Tumors
Marketed as BNT327, the PD-L1xVEGF-A bispecific antibody has the potential to become what the involved parties believe is a ‘foundational immuno-oncology backbone.’
How Geospatial Mapping Reveals the Impact of Pharmacy Closures
In the first part of her Pharma Commerce video interview, Maggie McCullough, PolicyMap’s CEO, explains how geospatial mapping can help identify and address emerging pharmacy deserts across the United States.
Pharma Pulse 6/5/25: Forging a Brighter Future for Rare Disease Outcomes with Specialty Pharmacy Utilization; Rethinking Clinical Trial Efficiency Amidst Cost Pressures on Pharma
The Tariff Effect: Greater Supply Chain Prepares for Repercussions
Potential import taxes on pharma goods entering the United States continue to have effects on the industry in more ways than one.
Driving Supply Chain Resilience
In the final part of his Pharma Commerce video interview, Scott Tillman, Logility’s senior vice president of innovation, discusses how uncertainty can help reshape the way organizations prioritize supply chain investments.
Pharma Pulse 6/4/25: Five Critical Challenges in Investigator Site Selection and How Clinical Data Science Can Solve Them; Wegovy Use Up 50% Among US Teens
Why CX Is a Difference Maker for Pharma
Direct-to-consumer and direct-to-patient models are major contributors.
Overcoming Legacy Systems
In the fourth part of his Pharma Commerce video interview, Scott Tillman, Logility’s senior vice president of innovation, explains how migrating to cloud-based systems can help overcome this challenge.
Pharma Pulse 6/3/25: Preparing for the Pharma C-Suite; America’s Vanishing Scientific Research Workforce is a Threat to Public Health
Amplifying Workforce Development
In the third part of his Pharma Commerce video interview, Scott Tillman, Logility’s senior vice president of innovation, comments on the role of automation and GenAI evolving in workforce development.
Bora Expands Baltimore Facility, Adds Automated Fill-Finish Line
The installation of the new vial, syringe, and cartridge line is expected to take place throughout the coming year.
Being Digitally Optimized
In the second part of his Pharma Commerce video interview, Scott Tillman, Logility’s senior vice president of innovation, discusses the common misconceptions supply chain leaders might have around the term, and why the processes around optimization need to change.
How Recent Executive Orders Impact the Drug Pricing Landscape
Alice Valder Curran outlines the steps manufacturers should take to better prepare for upcoming executive actions on drug pricing and market access.
Bridging the GenAI Adoption Gap in Supply Chain
In the first part of his Pharma Commerce video interview, Scott Tillman, Logility’s senior vice president of innovation, describes the disparity in organizations utilizing supply-chain specific applications.
